SchumacherGABeebeGKiblerRF, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci1965; 122: 552–568.
2.
ZhangKZhaoYLiangZ, et al. Validity of the McDonald criteria in predicting second events in multiple sclerosis. Mult Scler Relat Disord2020; 43: 102223.
HagensMHBurggraaffJKilsdonkID, et al. Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study. Mult Scler2019; 25(3): 352–360.
5.
Lebrun-FrenayCKantarciOSivaA, et al. Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol2020; 88(2): 407–417.
6.
FilippiMPreziosaPBanwellBL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines. Brain2019; 142: 1858–1875.
7.
SolomonAJArrambideGBrownleeWJ, et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol2023; 22: 750–768.
8.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
9.
MartireMSMoiolaLRoccaMA, et al. What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis. Expert Rev Neurother2022; 22(10): 829–837.
10.
CagolACorteseRBarakovicM, et al. Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis. JAMA Neurol. Epub ahead of print 11 December 2023. DOI: 10.1001/jamaneurol.2023.4737.
